Fiji’s Parliament passed the HIV/AIDS (Amendment) Bill 2026 on Thursday, clearing the way for a needle and syringe exchange programme aimed at containing the rapid rise of HIV from intravenous drug use.
The country’s Health Ministry described the vote as a “monumental milestone” in the fight against HIV/AIDS, according to RNZ, which reported the passage on 1 October. Asia Pacific Report carried the same account a day later.
Key facts
- The law is the HIV/AIDS (Amendment) Bill 2026, passed by Parliament on Thursday.
- It introduces what RNZ describes as evidence-based harm reduction programmes, and is being hailed as a “lifeline” for the country.
- The Government declared an HIV emergency last month, RNZ reported.
- Fiji has one of the fastest-growing HIV rates in the world, according to RNZ.
- Dr Atonio Lalabalavu, identified by RNZ with Fiji’s Health Ministry, set out what the harm-reduction measures may permit.
- Australia, New Zealand and Papua New Guinea are the only other Pacific countries with a formal needle and syringe programme, both outlets report.
- Further measures can be approved by the health minister on the recommendation of the HIV/AIDS Board, without new legislation.
- The Health Ministry announced the milestone in a Facebook post, both outlets report.
Why it matters
RNZ reports that one in 60 Fijian adults now living with HIV was the figure behind last month’s emergency declaration.
Until this vote, there was no legal basis in Fiji for handing out sterile injecting equipment. Possession of needles sat on the policing side of the ledger rather than the health side; the amendment moves it across.
That shift puts Fiji in line with the approach international health bodies already recommend. The World Health Organization’s published HIV guidance lists people who inject drugs among the key populations at heightened risk of infection, and the harm-reduction package WHO sets out for that group — developed with UNODC and UNAIDS — includes needle and syringe programmes alongside condoms, testing, treatment and PrEP.
UNAIDS, for its part, maintains the country-level estimates against which Fiji’s outbreak is measured. Neither body had issued a statement on Thursday’s vote in the reporting available at the time of writing.
In its Facebook post, the Health Ministry said the Bill “legalises compassion” and “builds a protective bridge of healthcare to the most vulnerable among us”, as quoted by Asia Pacific Report. The Ministry was also explicit about what the law does not do: “To be clear: this does not legalise illicit drugs.”
What the Bill permits
The supply side
Dr Lalabalavu told RNZ the measures include the free distribution of skin-penetrating instruments, including needles and syringes, condoms and condom lubricants, and pre-exposure prophylaxis (PrEP) — a medicine taken by people who are HIV-negative to prevent infection.
The provision also extends to “other means of HIV prevention”, a phrase RNZ reports without further definition from the Ministry.
The return and referral side
Dr Lalabalavu said the programmes may also provide facilities for the safe return and management of used items, targeted counselling, HIV/AIDS awareness information and materials, and referrals to HIV treatment, rehabilitation, mental health and other health and social support services.
Read together, that is a two-sided design. Clean equipment goes out on one side; a return and disposal channel operates on the other, with counselling and referral attached so that a visit for needles can become an entry point to treatment. The Ministry’s own framing — a “bridge” to vulnerable people — points the same way.
Who will deliver it
The Health Ministry said the law allows “our frontline health heroes, pharmacies, and peer outreach workers” to distribute sterile equipment, condoms, PrEP and counselling, RNZ reported.
Two things in that sentence matter. The first is pharmacies: the delivery network extends beyond government clinics into retail premises. The second is peer outreach workers — people with lived experience of drug use, who are usually the only workers able to reach injecting networks that avoid formal health services.
The Ministry said the legislation is grounded in human rights, confidentiality and freedom from discrimination, and that it lets those workers operate “safely and without fear”, according to RNZ. That protection is the practical hinge of any needle programme: outreach staff and clients both have to believe a handover will not end in a prosecution.
The Pacific’s fourth programme
Australia, New Zealand and Papua New Guinea are the only Pacific nations that currently run a formal needle and syringe programme, both RNZ and Asia Pacific Report state. Fiji’s vote makes it the fourth.
That is the single clearest measure of how unusual the decision is in the region — and also the limit of what the two reports establish. Neither compares Fiji’s intended scheme with the Australian, New Zealand or Papua New Guinean models, and neither quotes officials or programme operators from any of the three.
The emergency behind the law
Both outlets tie the legislation directly to injecting drug use as the driver of Fiji’s HIV increase. RNZ describes the Bill as aimed at containing the rapid rise of HIV from intravenous drug use, and says the emergency was declared last month.
Fiji News has covered the health and policing sides of that picture separately, including reporting on methamphetamine use across the region and on Fiji’s high-profile drug investigations.
The two reports on this week’s vote do not link the Bill to any specific enforcement case. Neither sets out how police practice will change now that possession of distributed equipment has a lawful basis.
What the reports don’t say
Rollout and money
Neither RNZ nor Asia Pacific Report gives a start date for the programme, a budget figure in Fijian dollars, a staffing plan, or a list of sites where equipment will be handed out.
Neither says how many pharmacies or peer outreach workers will take part, or how they will be authorised to hold and distribute needles.
No cost figure of any kind appears in either account, and no finance official, economist or employer body is quoted on what the programme will cost or save. The caseload itself is also unbroken-down: the one-in-60 ratio is reported as a share of adults, with no breakdown by age band, occupation, region or gender in either report.
The parliamentary record
Neither report records the voting numbers in Parliament, names MPs who spoke for or against the Bill, or reports any opposition argument.
That is a notable absence for a measure both outlets describe as a milestone, and it means the public case against the Bill — if one was made in the chamber — is not on the record in either account.
Voices not heard
Neither report quotes a health NGO, a drug-user organisation or a UN agency responding to the vote.
Asia Pacific Report carries the same quotes and figures as RNZ, with no additional detail on cost, coverage or rollout. No third independent account of the vote had surfaced at the time of writing, which means every fact above traces back to one set of Health Ministry statements.
What to watch next
The clearest signal in the legislation is the mechanism for widening it. Further harm-reduction measures can be approved by the health minister on the recommendation of the HIV/AIDS Board, which means the next expansion of the programme may arrive as an administrative decision rather than a parliamentary debate — and may be easier to miss.
Three things will show whether the law is working rather than merely passed. The first is the first published count of sites and distribution points. The second is whether pharmacies actually enrol, given the stigma attached to the service.
The third is whether Fiji’s next reported HIV figures — from the Ministry of Health and Medical Services, and in the UNAIDS country estimates — bend. None of those exist yet.
Where the sources are vague — on dates, on scale, on debate — this article stays vague too, and will be updated if the Ministry, Parliament or an international agency publishes more.
Frequently Asked Questions
What exactly does Fiji’s HIV/AIDS (Amendment) Bill 2026 allow?
Dr Atonio Lalabalavu of Fiji’s Health Ministry told RNZ the measures cover free distribution of skin-penetrating instruments including needles and syringes, condoms and lubricants, pre-exposure prophylaxis (PrEP) and other means of HIV prevention. He said programmes may also provide safe return and disposal of used equipment, targeted counselling, awareness materials and referrals to treatment, rehabilitation, mental health and social support services.
Which other Pacific countries already run a formal needle and syringe programme?
Australia, New Zealand and Papua New Guinea are the only Pacific nations with a formal needle and syringe programme, according to RNZ and Asia Pacific Report. With the passage of the HIV/AIDS (Amendment) Bill 2026, Fiji becomes the fourth. Neither report describes how Fiji’s scheme will be designed compared with those three, and neither quotes officials from any of them.
Does the new law match international health guidance?
Broadly, yes. The World Health Organization’s published HIV guidance lists people who inject drugs among the key populations at heightened risk, and the harm-reduction package WHO sets out for that group includes needle and syringe programmes alongside condoms, testing, treatment and PrEP. WHO had not published a statement specifically on Fiji’s vote in the reporting available at the time of writing.
Can more harm-reduction measures be added later without another Bill?
Yes. Dr Atonio Lalabalavu told RNZ the Bill allows additional measures to be approved by the health minister on the recommendation of the HIV/AIDS Board, where those measures are necessary. That means the scope of the programme can widen administratively, without a further parliamentary vote.
What protections does the legislation set out for people who use the services?
The Health Ministry said the legislation is grounded in human rights, confidentiality and freedom from discrimination, according to RNZ. The Ministry said it lets health workers, pharmacies and peer outreach workers operate safely and without fear.
Does the new law make illicit drug use legal in Fiji?
No. In a Facebook post quoted by RNZ and Asia Pacific Report, the Health Ministry said: “To be clear: this does not legalise illicit drugs.” The Ministry framed the law instead as a protective bridge of healthcare to vulnerable people.
When does the needle exchange programme start, and what will it cost?
Neither RNZ nor Asia Pacific Report gives a start date, a budget figure in Fijian dollars, a staffing plan or a list of distribution sites. No finance official, employer body or economist is quoted on cost in either account.
Where can readers check official HIV data for Fiji?
UNAIDS publishes country-level HIV estimates for Fiji, and the World Health Organization publishes global HIV guidance and fact sheets. Fiji’s Ministry of Health and Medical Services is the source of the national figures cited in the emergency declaration. None of those bodies had published a statement on this week’s vote in the two reports reviewed for this article.
